| INNOVENT BIOLOGICS INC. |
| China |
| Gesundheit |
| KYG4818G1010 / A2N7N8 |
| 6IB (Frankfurt) |
| FRA:6IB, ETR:6IB, 6IB:GR |
| - |
| https://en.innoventbio.co.. |
|
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, ..
>Volltext.. |
| 17320.15 Mio. EUR |
| 15448.76 Mio. EUR |
| 1592.03 Mio. EUR |
| 319.32 Mio. EUR |
| 98.24 Mio. EUR |
| 0.06 EUR |
| 352.75 Mio. EUR |
| 1299.81 Mio. EUR |
| 1258.52 Mio. EUR |
| 2.17 |
| 21.91% |
| - |
| - |
| - |
| - |
| - |
| INNOVENT BIOLOGICS, INNOVENT BIO |
| 15.07.26 |
|